Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

AviadoBio is focusing on neurodegenerative diseases and has emerged from stealth with nearly $100m in total from investors including Johnson & Johnson Innovation – JJDC.

Spun out of King’s College London, AviadoBio is focusing on neurodegenerative diseases and has emerged from stealth with nearly $100m in overall funding.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Access Industries subsidiary Access Biotechnology co-led a round disclosed by the radiopharmaceutical drug developer as it publicly launched.

Mercedes-Benz and Stellantis made strategic investments in advanced battery developer Factorial Energy while celluar therapy developer Mana Therapeutics closed its $42m series A round.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Sonic Healthcare and I-Med Radiology Network helped the smart diagnostics technology developer secure $91.6m that will be used to accelerate its expansion into new medical areas and scale its team.

Merck & Co and SR One were among the investors in a series C round for the small molecule drug developer led by Pivotal BioVenture Partners.